Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleMethodology

Carbon-11-Labeled Daunorubicin and Verapamil for Probing P-Glycoprotein in Tumors with PET

Philip H. Elsinga, Eric J.F. Franssen, N. Harry Hendrikse, Lizette Fluks, Anne-Miek A. Weemaes, Winette T.A. van de Graaf, Elisabeth G.E. de Vries, Gerben M. Visser and Willem Vaalburg
Journal of Nuclear Medicine September 1996, 37 (9) 1571-1575;
Philip H. Elsinga
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric J.F. Franssen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. Harry Hendrikse
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lizette Fluks
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne-Miek A. Weemaes
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Winette T.A. van de Graaf
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisabeth G.E. de Vries
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerben M. Visser
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Willem Vaalburg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 37, Issue 9
September 1, 1996
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Carbon-11-Labeled Daunorubicin and Verapamil for Probing P-Glycoprotein in Tumors with PET
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Carbon-11-Labeled Daunorubicin and Verapamil for Probing P-Glycoprotein in Tumors with PET
Philip H. Elsinga, Eric J.F. Franssen, N. Harry Hendrikse, Lizette Fluks, Anne-Miek A. Weemaes, Winette T.A. van de Graaf, Elisabeth G.E. de Vries, Gerben M. Visser, Willem Vaalburg
Journal of Nuclear Medicine Sep 1996, 37 (9) 1571-1575;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Carbon-11-Labeled Daunorubicin and Verapamil for Probing P-Glycoprotein in Tumors with PET
Philip H. Elsinga, Eric J.F. Franssen, N. Harry Hendrikse, Lizette Fluks, Anne-Miek A. Weemaes, Winette T.A. van de Graaf, Elisabeth G.E. de Vries, Gerben M. Visser, Willem Vaalburg
Journal of Nuclear Medicine Sep 1996, 37 (9) 1571-1575;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Multiagent PET for Risk Characterization in Sarcoma
  • Tariquidar-Induced P-Glycoprotein Inhibition at the Rat Blood-Brain Barrier Studied with (R)-11C-Verapamil and PET
  • In Vivo Evaluation of P-Glycoprotein Modulation of 8 PET Radioligands Used Clinically
  • Quantitative Analysis of 11C-Verapamil Transfer at the Human Blood-Brain Barrier for Evaluation of P-glycoprotein Function
  • Characterization of a 67Ga/68Ga Radiopharmaceutical for SPECT and PET of MDR1 P-Glycoprotein Transport Activity In Vivo: Validation in Multidrug-Resistant Tumors and at the Blood-Brain Barrier
  • Molecular Targeting with Radionuclides: State of the Science
  • A New in Vivo Method to Study P-Glycoprotein Transport in Tumors and the Blood-Brain Barrier
  • Google Scholar

More in this TOC Section

  • A “Hybrid” Method for Measuring Myocardial Wall Thickening from Gated PET/SPECT Images
  • No-Carrier-Added Iodine-131-FIBG: Evaluation of an MIBG Analog
  • Weighted Summation of Oxygen-15-Water PET Data to Increase Signal-to-Noise Ratio for Activation Studies
Show more Methodology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire